PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'nference, Cambridge, Massachusetts.\', \'nference Labs, Murgesh Pallya, Bengaluru, Karnataka, India.\', \'Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jamanetworkopen.2021.32540
?:doi
?:hasPublicationType
?:journal
  • JAMA network open
is ?:pmid of
?:pmid
?:pmid
  • 34726743
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34726743>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34726743>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all